IRVINE, Calif., March 9, 2018 /PRNewswire/ -- AAOS 2018 —
Halyard Health (NYSE: HYH), a medical technology company
focused on eliminating pain, speeding recovery and preventing
infection, today announced the availability of ON-Q* TRAC 3.0, the
latest version of its online patient engagement platform allowing
physicians to monitor, measure and track patients' post-operative
satisfaction and pain to improve the overall patient
experience.1 ON-Q TRAC 3.0, along with Halyard's full
suite of pain management products, is currently on display at
Halyard booth #6233 at the American Academy of Orthopaedic Surgeons
(AAOS) 2018 Annual Meeting.
The new ON-Q TRAC 3.0 platform allows physicians to set
pre-configurable threshold notifications, allowing for direct
follow-up on specific care metrics that exceed providers'
acceptable recovery values including pain, sleep, functional
activity and more. Additionally, ON-Q TRAC 3.0 includes
capabilities for real-time alerts via text or email that can help
physicians to better track key outcome data and patient feedback
and provide opportunities for appropriate intervention to
potentially reduce readmissions and lower opioid consumption.
Studies show that increased physician to patient connectivity
enhances patient satisfaction scores, helps improve outcomes and
can boost reputation and referrals.1,2,3,4,5,6
With ON-Q TRAC 3.0, physicians are also able to benchmark and
compare their patients' progress against other patients and
physician practices around the country in the ON-Q TRAC database.
This enhanced analysis provides physicians with deeper insights
into how their patients' progress compares to other facilities so
they can quickly and efficiently modify protocols and treatment
plans for improved outcomes.
Additional ON-Q TRAC 3.0 analytical upgrades include:
- New chart drill-down functionality allows providers to easily
analyze outcomes at the individual patient case level.
- Resource center featuring Halyard patient education materials,
which can be delivered directly to patients via a web-browser or
smartphone.
- Ability to compare outcomes between pain management modalities
to evaluate the effect of different treatments to ensure optimal
patient recovery.
"Between 1999 and 2013, the prescription opioid overdose rate
for adults aged 55 to 64 increased more than seven times," said
Roger Massengale, general manager,
acute pain, Halyard Health. "It's clear that the healthcare
community needs to find a better way of fostering open
communication between patients and their providers regarding
post-surgical pain management. By combining real-time alerts and
powerful analytics, ON-Q TRAC 3.0 is designed to help Halyard's
customers better manage their patients' pain and make more informed
decisions regarding need to prescribe opioids post-surgery."
To learn more about ON-Q TRAC 3.0, which includes Spanish
language interface, please visit
http://www.halyardhealth.com/ON-QTRAC.
ON-Q TRAC is not a medical device.
About ON-Q TRAC
ON-Q TRAC helps engage patients, enhance connectivity and
improve collaboration between patients and physicians. Patients are
enrolled in the platform before surgery and are invited to provide
information at various time intervals – from pre-operative through
90-days post-surgery – via a user-friendly survey that can be
completed on either a desktop or mobile device. Based on this
patient input, physicians are able to track patients' pain levels
and satisfaction with their treatment and care.
About Halyard Health
Halyard Health (NYSE: HYH) is a medical technology company
focused on eliminating pain, speeding recovery and preventing
infection for healthcare providers and their
patients. Headquartered in Alpharetta, Georgia, Halyard is committed to
addressing some of today's most important healthcare needs, such as
reducing the use of opioids while helping patients move from
surgery to recovery. Halyard's Medical Device business develops,
manufactures and markets clinically superior solutions that improve
medical outcomes and business performance in more than 90
countries. For more information, visit www.halyardhealth.com.
*Registered Trademarks or Trademarks of Halyard Health, Inc. or
its affiliates.
1 Heller L, Kowalski AM, Wei C, Butler CE.
Prospective, randomized, double-blind trial of local anesthetic
infusion and intravenous narcotic patient-controlled anesthesia
pump for pain management after free TRAM flap breast
reconstruction. Plast Reconstr Surg. 2008;122(4):1010-1018.
2 Liu SS, Richman JM, Thirlby RC, Wu CL. Efficacy of
continuous wound catheters delivering local anesthetic for
postoperative analgesia: a quantitative and qualitative systematic
review of randomized controlled trials. J Am Coll Surg.
2006;203(6):914-932.
3 Beaussier M, El'Ayoubi H, Schiffer E, et al.
Continuous preperitoneal infusion of ropivacaine provides effective
analgesia and accelerates recovery after colorectal surgery.
Anesthesiology. 2007;107(3):461-468.
4 Bingham AE, Fu R, Horn JL, Abrahams MS. Continuous
peripheral nerve block compared with single-injection peripheral
nerve block: a systematic review and meta-analysis of randomized
controlled trials. Reg Anesth Pain Med. 2012;37(6):583-594.
5 Kean J, Wigderowitz CA, Coventry DM. Continuous
interscalene infusion and single injection using levobupivacaine
for analgesia after surgery of the shoulder: a double-blind,
randomized controlled trial. J Bone Joint Surg [Br].
2006;88-B:1173-1177.
6 Husain A, Lee GC. Establishing realistic patient
expectations following total knee arthroplasty. J Am Acad Orthop
Surg. 2015;23(12):707-713.
View original content with
multimedia:http://www.prnewswire.com/news-releases/halyard-health-upgrades-on-q-trac-patient-engagement-platform-for-physicians-and-hospitals-300611289.html
SOURCE Halyard Health